Welcome to Heart Matters – Empowering Heart Health
Conditions

Understanding Ventricular Tachycardia: A Potentially Life-Threatening Arrhythmia

The heart’s intricate network of electrical pathways governs the rhythm that sustains our body’s functioning. Yet, disruptions can occur, giving rise to abnormal heart rhythms or arrhythmias. One of these is ventricular tachycardia (VT), a condition with potentially significant implications for cardiovascular well-being. This article examines ventricular tachycardia, encompassing its origins, symptoms, diagnosis, and some of the potential treatment considerations.

Understanding Ventricular Tachycardia (VT)

Ventricular tachycardia is a rapid heart rhythm originating from the ventricles, the lower chambers of the heart responsible for pumping oxygenated blood to the rest of the body. In VT, the ventricles beat abnormally fast, exceeding 100 beats per minute, and more often greater than 150bpm. This abnormal rhythm disrupts the heart’s pumping action, potentially leading to decreased blood flow and compromising organ function. See below illustrative animation demonstrating the electrical stimuli arising from the lower chambers of the heart.

 

 

Causes of Ventricular Tachycardia

Various factors can influence ventricular tachycardia’s development and predispose individuals. Common associations include structural heart diseases (like coronary artery disease, heart attacks, cardiomyopathy, and heart valve abnormalities), as well as genetic conditions, electrolyte imbalances, drug interactions, and prior heart surgeries. During diagnosis, it’s crucial to carefully assess these potential causes, including any underlying conditions or risk-raising factors.

Importantly, VT’s causes are often multifaceted, with individual cases influenced by a combination of these factors. Swift diagnosis and management are vital for effectively addressing both VT and its underlying triggers.

A summary of some causes that need to be considered:

  1. Coronary Artery Disease: Narrowed or blocked coronary arteries can disrupt blood flow to the heart muscle, leading to abnormal electrical impulses that trigger VT.
  2. Heart Attack (Myocardial Infarction): The damage to the heart muscle caused by a heart attack can create a substrate for VT to develop. 
  3. Cardiomyopathy: Conditions such as dilated cardiomyopathy or hypertrophic cardiomyopathy can lead to structural changes in the heart that increase the risk of VT.
  4. Heart Failure: A weakened heart muscle and impaired pumping function can create an environment conducive to VT.
  5. Electrolyte Imbalances: Abnormal levels of potassium, magnesium, or other electrolytes can disrupt the heart’s electrical signals and trigger VT.
  6. Long QT Syndrome: Inherited genetic disorders that affect the heart’s electrical system can lead to irregular heartbeats, including VT. More details here.
  7. Brugada Syndrome: Another inherited genetic disorder that can cause abnormal heart rhythms, including VT.
  8. Drug Side Effects: Certain medications, especially those that affect the heart’s electrical conduction, can increase the risk of VT.
  9. Stimulant Abuse: Excessive consumption of stimulants or illicit drugs can trigger abnormal heart rhythms, including VT.
  10. Scar Tissue from Prior Heart Surgery: Surgical procedures can lead to scar tissue formation that disrupts normal electrical pathways, increasing the risk of VT.
  11. Inflammatory Conditions: Conditions like myocarditis (inflammation of the heart muscle) can lead to VT.
  12. Certain Genetic Mutations: Specific genetic mutations can make individuals more susceptible to developing VT.
  13. Acute Illness or Stress: Severe illness or intense physical or emotional stress can sometimes trigger VT, especially in individuals with underlying heart conditions.
  14. Abnormal Heart Valves: Conditions like mitral valve prolapse can lead to VT in some cases.

 

Recognizing the Symptoms

 The symptoms of ventricular tachycardia can vary depending on the severity and duration of the episodes. Some individuals may remain asymptomatic, while others may experience palpitations, rapid and irregular pulse, lightheadedness, dizziness, chest pain, shortness of breath, fainting, or even cardiac arrest. It is crucial to seek medical attention if any of these symptoms are experienced.

This ECG depicts a clear example of monomorphic ventricular tachycardia (VT) characterized by a consistent QRS morphology and a rapid heart rate. The distinctive feature of monomorphic VT is the uniform appearance of QRS complexes on the ECG, reflecting a single origin of the arrhythmia. The rapid ventricular rate is indicative of the sustained nature of this tachycardia

Diagnosing Ventricular Tachycardia

Prompt and precise diagnosis of ventricular tachycardia is vital for effective management. The diagnostic process is multifaceted, beginning with a thorough review of the patient’s medical history and a comprehensive physical examination. These initial steps lay the foundation for further diagnostic assessments, which encompass:

  • Electrocardiograms (ECGs or EKGs): These play an important role in identifying VT episodes and possible origins by recording the heart’s electrical activity.
  • Heart monitors / event monitors: These devices allow continuous monitoring to capture any irregularities that might not show up during short-term ECGs.
  • Echocardiography: This imaging technique utilizes sound waves to create detailed images of the heart’s structure and function, aiding in identifying any structural abnormalities.
  • Stress tests: By observing the heart’s response to physical exertion, stress tests provide valuable information about its functionality and potential triggers for VT.
  • Cardiac MRI: This advanced imaging technology provides highly detailed images of the heart, aiding in the assessment of its structure and identifying potential causes of VT.
  • Electrophysiological studies: These studies involve detailed mapping of the heart’s electrical pathways and may be conducted to precisely identify the origins of VT and assess the condition’s severity.

Together, these assessments help medical professionals gain a comprehensive understanding of the underlying causes and characteristics of ventricular tachycardia, enabling informed decisions about management and treatment strategies.

 

Cardiac MRI offers a non-invasive way to visualize the heart’s structure, identify underlying structural abnormalities, and accurately locate the origin of the tachycardia. By providing detailed insights into myocardial tissue, scar tissue, and overall cardiac function, cardiac MRI plays a crucial role in guiding treatment strategies and improving the management of VT patients.

Treatment Options for Ventricular Tachycardia

 

Ventricular tachycardia is typically addressed by specialized cardiologists who have undergone sub-specialty training in the heart’s electrical/conduction system and the management of arrhythmias. Therefore, it may not be uncommon for your cardiologist to refer you to a colleague with this expertise.

The management of ventricular tachycardia aims to prevent life-threatening complications and restore normal heart rhythm. The treatment strategy depends on several factors, including the severity of symptoms, underlying causes, and associated risks. Options range from medication to medical devices and invasive procedures. 

  1. Medications: Antiarrhythmic drugs are often prescribed to control ventricular tachycardia episodes. Medications like beta-blockers, calcium channel blockers, and sodium channel blockers work by regulating the electrical impulses in the heart.
  2. Implantable Cardioverter-Defibrillator (ICD): For some individuals who are assessed as having a high risk of cardiac arrest or recurrent VT episodes, an ICD may be implanted. This device continuously monitors the heart’s rhythm and delivers a shock internally to restore normal rhythm if a dangerous arrhythmia is detected.
  3. Catheter Ablation: In certain cases, catheter ablation may be recommended. This minimally invasive procedure involves the insertion of a catheter into the heart to destroy the abnormal electrical pathways causing VT.
  4. Acute Cardiac Defibrillation: In situations where ventricular tachycardia persists and poses a threat to vital functions, such as blood pressure, immediate intervention becomes necessary. In these cases, a cardiac defibrillator may be utilized to perform cardioversion, a process that involves delivering a controlled electric shock to the chest. This procedure aims to restore a normal heart rhythm and overcome the irregularities associated with ventricular tachycardia.

 

Preventive Measures

 While ventricular tachycardia can be a serious condition, there are steps individuals can take to reduce the risk of developing or worsening the condition. Lifestyle modifications such:

  1. Embracing a Heart-Healthy Lifestyle: We keep returning to this message often in our heart health articles. Incorporating a heart-healthy lifestyle can have a profound impact on overall outcomes when it comes to cardiovascular disease. By paying careful attention to underlying risk factors, you can optimize long-term results. Prioritizing regular exercise, maintaining a healthy weight, abstaining from tobacco products, and practicing moderate alcohol consumption are all crucial components for promoting cardiovascular well-being.
  2. Medication Compliance: If prescribed antiarrhythmic medications, it is crucial to take them as directed by the healthcare provider. Skipping doses or abruptly stopping medication can increase the risk of rhythm disorders. It is important to communicate with the healthcare team regarding any concerns or side effects experienced.
  3. Effective Management of Underlying Conditions: Ensuring proper management of underlying heart conditions, including coronary artery disease, cardiomyopathy, or heart valve disorders, plays a pivotal role in preventing ventricular tachycardia. Regular check-ups, diligent adherence to treatment plans, and following healthcare recommendations are essential for maintaining optimal heart health. Collaborating closely with local healthcare professionals ensures your condition is diligently monitored, empowering you to lead a fulfilling life to the fullest extent.
  4. Regular Follow-up and Monitoring: Routine follow-up appointments with healthcare providers are essential for monitoring the condition and adjusting treatment plans if necessary. Regular check-ups allow for ongoing evaluation of the heart’s function, assessment of medication effectiveness, and detection of any changes in symptoms.

Conclusion

 Ventricular tachycardia is a heart rhythm disorder that requires a comprehensive understanding, timely diagnosis, and proper management. By recognizing the symptoms, seeking prompt medical attention, and following recommended treatment strategies, individuals can minimize the risks associated with VT and enhance their quality of life. Additionally, adopting a heart-healthy lifestyle, effectively managing underlying conditions, adhering to prescribed medications, avoiding triggers, and maintaining regular follow-up appointments can greatly reduce the likelihood of VT episodes and potential complications. Remember, when it comes to matters of the heart, knowledge, and proactive care are vital for a healthier and more informed future.

About the author

Heart Matters, edited by cardiologist Professor Peter Barlis, is a trusted resource that offers clear and accurate information on cardiovascular health. It bridges the gap between scientific research and everyday understanding, empowering you to make informed choices and take an active role in supporting your heart health.

Our Youtube Channel

Discover our Heart Matters YouTube channel, where we bring heart health to life. From explaining common conditions and symptoms to discussing the latest research, our engaging videos simplify complex topics, ensuring you have access to valuable knowledge for a healthier heart. Subscribe now and embark on a journey of education, empowerment, and inspiration.

Editor's Picks

Subscribe to our newsletter and be the first to receive valuable insights, tips, and resources on heart health.

other anti-anginals

When first-line therapies for angina, such as beta blockers, calcium channel blockers, and nitrates, prove inadequate or are not well-tolerated, second-line therapies may be considered.
Perhexiline is a unique medication that enhances the heart's ability to utilize fatty acids for energy, reducing its reliance on oxygen and lowering oxygen demand. This action helps improve blood flow and alleviates chest pain in some patients with refractory angina.
Nicorandil is another second-line option with a dual mechanism of action. It opens potassium channels in smooth muscle cells, causing vasodilation and enhancing coronary blood flow. Additionally, nicorandil also stimulates nitric oxide release, further dilating blood vessels and reducing heart workload.
Trimetazidine is an anti-ischemic agent that improves cardiac efficiency by enhancing glucose metabolism and shifting the heart's energy production to a more oxygen-efficient process. As second-line therapies, these medications offer alternative approaches for managing angina in individuals who do not respond adequately to first-line treatments or those experiencing side effects from other medications.

lipid lowering therapies

Lipid-lowering therapies are essential in managing coronary artery disease (CAD), a condition where the arteries supplying blood to the heart become narrowed. Among the most commonly prescribed treatments are statins, which reduce cholesterol production in the liver and significantly lower the risk of heart attacks and strokes.

Other medications may be used to target different aspects of lipid metabolism:

  • Ezetimibe helps reduce the absorption of cholesterol in the gut
  • Fibrates lower triglyceride levels
  • Niacin can help raise high-density lipoprotein (HDL) cholesterol

In recent years, a newer class of medications known as PCSK9 inhibitors—such as Repatha (evolocumab)—has become available. These drugs block a specific enzyme involved in cholesterol regulation and can dramatically lower LDL cholesterol, particularly in patients who do not achieve target levels with statins alone.

Together, these therapies provide a range of options to personalise treatment and improve cardiovascular outcomes.

Nitrates

Nitrates for Angina Relief

Nitrates are widely used to treat angina and provide quick relief from chest pain. These medications are commonly available as sublingual sprays or tablets, skin patches, and long-acting tablets.

Nitrates work by dilating blood vessels, allowing for increased blood flow and reduced vascular resistance. This reduces the heart’s workload and lowers its oxygen demand, offering prompt relief from angina symptoms.

Sublingual nitrates act quickly and are typically used at the onset of angina symptoms, while patches and long-acting tablets are used for ongoing prevention.

Common side effects include headaches, dizziness, and flushing. These often improve with continued use but should be discussed with a healthcare provider if persistent or bothersome.

calcium channel blockers

Calcium channel blockers, including amlodipine, felodipine, Cardizem (diltiazem), and verapamil, are commonly prescribed for the treatment of angina.

These medications work by inhibiting the influx of calcium into the muscle cells of the heart and blood vessels, causing them to relax. This relaxation leads to the widening of blood vessels, which improves blood flow and reduces blood pressure.

For individuals with angina, calcium channel blockers reduce the heart’s workload and oxygen demand, helping to relieve chest pain and prevent angina episodes.

While effective, they may cause side effects such as headaches, dizziness, facial flushing, and ankle swelling. These effects should be monitored and discussed with your healthcare provider if they persist.

Beta blockers

Beta blockers, such as metoprolol, propranolol, atenolol, carvedilol, and bisoprolol, play a crucial role in managing angina.

These medications work by blocking specific receptors in the heart, which slows the heart rate and reduces the strength of each contraction. This results in a lower oxygen demand by the heart and helps relieve chest pain associated with angina.

Beta blockers are highly effective in both relieving symptoms and preventing angina episodes. However, they may cause side effects in some individuals, including tiredness, worsened asthma symptoms, more vivid dreams, and erectile dysfunction in some males.

It is important to consult your healthcare provider to determine whether beta blockers are a suitable option for your angina and overall heart health.

Anti-platelet Medications

Anti-platelet medications play a crucial role in preventing blood clot formation and reducing the risk of serious cardiovascular events such as heart attacks and strokes. Commonly used agents include aspirin, clopidogrel, and ticagrelor.

 

Aspirin: This well-known medication inhibits platelet activation, reducing the likelihood that platelets will clump together and form clots. It is widely used for both primary and secondary prevention of heart attacks and strokes.

 

Clopidogrel: A potent anti-platelet agent, clopidogrel works by blocking specific receptors on platelets to prevent aggregation. It is commonly prescribed for patients with acute coronary syndrome, those undergoing stent placement, and some individuals with peripheral arterial disease.

 

Ticagrelor: Ticagrelor also inhibits platelet activation and is typically used in the treatment of acute coronary syndrome. It is often prescribed alongside aspirin to provide dual anti-platelet therapy and further reduce the risk of heart-related events.